Caixin
China's medical exports tumble as world moves on from COVID
Medicines and equipment hit by weak demand amid slow global recovery
COVID vaccines
COVID vaccines
Moderna eyes local COVID vaccines for Japan, other countries
Chief Medical Officer Paul Burton highlights room for region-specific shots
COVID vaccines
Japan weighs recommending annual COVID shots for most
Once-a-year boosters would be given ahead of year-end holidays
COVID vaccines
Japan's 1st plant for mRNA COVID vaccine to be built by Daiichi Sankyo
Drugmaker targets capacity of 20m doses yearly, boosting nation's preparedness
The Big Story
China crests first infection wave since abandoning zero-COVID
Overloaded hospitals and morgues suggest true death toll is hidden and worst is to come
COVID vaccines
Japan's Daiichi Sankyo to seek OK for omicron booster by April 2024
Shionogi and KM Biologics also eye homegrown shots targeting variants
Economy
China's GDP growth to accelerate to 4.7% in 2023: Nikkei survey
Sudden policy changes, spread of virus cast shadow over 'V-shaped recovery'
Coronavirus
Chinese visitors lured by mRNA vaccines to Macao, Hong Kong
Mainlanders flock to enclave, prepare for Hong Kong border to reopen to get shots
.JPG?width=300&height=168&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms)
Coronavirus
China battles to keep hospitals open for COVID patients
Medics needed; drugstores told to limit ibuprofen sales to 6 pills per person per week
.jpg?width=300&height=168&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms)
COVID vaccines
Japan's Takara Bio to build another COVID vaccine factory
Company aims for 73m doses by fiscal 2027 to become dominant producer
International relations
Philippines receives cold trucks from Japan to deliver COVID shots
Logistics equipment to help boost vaccine shipments to islands
Opinion
Japan should reject WTO proposal to weaken COVID patents
Government's pandemic preparation plan depends on commitments from drugmakers
COVID vaccines
Indonesia's COVID vaccine shows region's push for third way
Jakarta now has homegrown halal alternative to Western, Chinese shots
COVID vaccines
Nasal vaccine for COVID-19 offers hope to emerging nations
No-needle products win approval in India and beyond
COVID vaccines
China builds plants for mRNA vaccines still in development limbo
CanSino, Sinopharm seek Chinese equivalents of Pfizer and Moderna shots
Caixin
How a Chinese mRNA COVID vaccine was approved in Indonesia
Southeast Asian country aims to be more self-sufficient in dealing with pandemic
The Big Story
Self-isolated: China's lonely zero-COVID battle in spotlight as Xi seeks third term
As 20th Party Congress approaches, China appears trapped by draconian anti-virus policies
COVID vaccines
Japan approves Pfizer vaccine for omicron variants BA.4, BA.5
Injections due to start this month with 43m doses to be supplied nationwide
Materials
AGC eyes Japanese output of mRNA to spur domestic COVID vaccines
Materials maker to invest in Yokohama plant, preparing for pandemics
Coronavirus
Indonesia authorizes emergency use of China's mRNA vaccine
Country also adopts homegrown jab as it looks to build local production
COVID vaccines
Moderna looks to build COVID vaccine plant in Japan, CEO says
Pharmaceutical first needs government to agree to long-term purchases of shots
COVID vaccines
Japan greenlights omicron COVID vaccines from Pfizer, Moderna
Rollout to start as early as September with vulnerable groups
DealStreetAsia
Malaysia's Navis to exit Europe medical cold chain company
Nasdaq-listed Azenta to acquire entire stake in vaccine storage provider B Med
COVID vaccines
Shionogi to file as soon as June for COVID shot green light
Homegrown vaccine developers inch closer to rollouts in Japan
COVID vaccines
China's vaccine diplomacy spoiled by omicron variant
Sinopharm, Sinovac and CanSino Biologics exports fall 97% on poor protection